Skip to content
ORICOric Pharmaceuticals, Inc.

Earnings

When Oric Pharmaceuticals, Inc. reports, what it reported each quarter, and how the stock took the results.

30 quarters. Mar 31, 2019 to Jun 30, 2026. mixed units.

Next results · Q3 2026Report filed

10-Q filed Nov 16, 2026

The 10-Q was filed Nov 16, 2026. Its figures are not on the desk yet.

Quarter
Q3 2026 · Ended Sep 30, 2026

Quarter by quarter

Q2 2026-$41.49MNo Q2 2025 on file

Latest results

  1. Q2 2026Aug 3, 2026, after the closeThe release+27.6%by the close of Aug 4
    Revenue
    —
    —
    Net income
    -$41.49M
    N/M
    EPS
    -$0.38
    N/M
  2. Q1 2026May 4, 2026, after the closeThe release0.3%by the close of May 5
    Revenue
    —
    —
    Net income
    -$35.77M
    N/M
    EPS
    -$0.34
    N/M
  3. Q4 2025Feb 23, 2026, after the closeThe release+14.5%by the close of Feb 24
    Revenue
    —
    —
    Net income
    -$30.51M
    N/M
    EPS
    —
    —
  4. Q3 2025Nov 13, 2025, after the closeThe release+0.4%by the close of Nov 14
    Revenue
    —
    —
    Net income
    -$32.59M
    N/M
    EPS
    -$0.33
    N/M

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q2 2026Jun 30, 2026Aug 3, 2026 · after-hoursAug 3, 202634 d10-Q——-$0.38+27.6%
Q1 2026Mar 31, 2026May 4, 2026 · after-hoursMay 4, 202634 d10-Q——-$0.340.3%
FY 2025
Q4 2025derivedDec 31, 2025Feb 23, 2026 · after-hoursFeb 23, 202654 d10-K———+14.5%
Q3 2025Sep 30, 2025Nov 13, 2025 · after-hoursNov 13, 202544 d10-Q——-$0.33+0.4%
Q2 2025Jun 30, 2025Aug 12, 2025 · after-hoursAug 12, 202543 d10-Q——-$0.47+2.9%
Q1 2025Mar 31, 2025May 5, 2025 · after-hoursMay 5, 202535 d10-Q——-$0.4211.6%
FY 2024
Q4 2024derivedDec 31, 2024Feb 18, 2025 · after-hoursFeb 18, 202549 d10-K———+1.3%
Q3 2024Sep 30, 2024Nov 12, 2024 · after-hoursNov 12, 202443 d10-Q——-$0.49+0.2%
Q2 2024Jun 30, 2024Aug 12, 2024 · after-hoursAug 12, 202443 d10-Q——-$0.45+11.8%
Q1 2024Mar 31, 2024May 6, 2024 · after-hoursMay 6, 202436 d10-Q——-$0.377.4%
Earlier years, FY 2019 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 16, 2026463577
10-QAug 3, 2026330631
10-QMay 4, 2026204047
10-KFeb 23, 2026064005
10-QNov 13, 2025280234
10-QAug 12, 2025107359
10-QMay 5, 2025063564
10-KFeb 18, 2025022273
10-QNov 12, 2024125471
10-QAug 12, 2024095467

Provenance

ProvenanceData status and checks

Oric Pharmaceuticals, Inc. · CIK 1796280 · Engraved from SEC EDGAR